NEW YORK (360Dx) – Chembio Diagnostics said after the close of the market on Thursday that its fourth quarter revenues grew 40 percent year over year.

For the three months ended Dec. 31, 2017, the company posted total revenues of $6.0 million, up from $4.3 million in the year-ago period. Product sales rose to $4.9 million from $3.2 million; licensing and royalty revenues were down to $263,902 from $315,835; and R&D, milestones and grant revenues increased to $854,965 from $712,122.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.